N/A (healthy adults)
Conditions
Interventions
Intake of one bottle (25 mL) of the test food per day for 8 weeks.
Sponsors
Anti-Aging Bank Co.,Ltd.
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: [1]Female aged between 35 and 60 at the time of informed consent [2]Individuals who are healthy and have no chronic physical disease including skin disease. [3]Individuals who are aware of skin deterioration such as elasticity and sagging [4]Individuals whose written informed consent has been obtained. [5]Individuals who can come to the designated venue for this study and be inspected. [6]Individuals judged appropriate for this study by a responsible doctor.
Exclusion criteria
Exclusion criteria: Individuals (who) [1]contract disease and are under treatment. [2]undergoing hormone replacement procedures. [3]with skin disease,such as atopic dermatitis. [4]used a drug to treat a disease in the past 1 month. [5]have a history of and/or contract serious diseases (eg,liver disease,kidney disease, heart disease,lung disease,blood disease). [6]whose BMI are 30 or more. [7]have allergic reaction to ingredients of test foods and other foods or drugs. [8]have a habit to use Foods with Function Claims, functional foods and/or supplements claiming to improve skin function and/or Anti-glycation in the past 3 months and/or are planning to use those foods during test periods. [9]drink more than 60g/day on average in terms of pure alcohol. [10]are smokers. [11]night worker. [12]with possible changes of life style during test periods. [13]will develop seasonal allergy symptoms, such as pollinosis, use an anti-allergic drug. [14]can't avoid direct sunlight exposure, such as sunburn, during test periods. [15]had been conducted an operation or beauty treatment on the test spot. [16]with scars or inflammation at the evaluation site, or feel that skin irritation affecting the examination occurs at the evaluation site before or after menstruation. [17]are or are possibly pregnant, or are breastfeeding. [18]are participating and/or had participated in other clinical studies within the last 3 months. [19]are judged as not appropriate to this study by a responsible doctor.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transepidermal water loss,Moisture of the skin surface,Skin viscoelasticity,Skin color quantification,Observation for skin condition by dermatologists | — |
Secondary
| Measure | Time frame |
|---|---|
| Fluorescent AGEs (AF) | — |
Countries
Japan
Contacts
Public ContactToshiyasu Tamura
TES Holdings Co., Ltd. Department of Clinical Trial
Outcome results
None listed